Clinical Trial Assessing the HERV-W Env Antagonist GNbAC1 for Efficacy in MS

Update Il y a 4 ans
Reference: NCT02782858

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The humanised IgG4 monoclonal antibody GNbAC1 targets the envelope protein (Env) of the human endogenous multiple sclerosis-associated retrovirus (HERV-W MSRV), which may play a critical role in multiple sclerosis (MS). This study evaluates the effect on MRI lesions parameters, the safety and pharmacokinetics of GNbAC1 in patients with relapsing remitting multiple sclerosis.


Inclusion criteria

  • Multiple Sclerosis Relapsing Remitting

Links